The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Gabapentin in the treatment of fibromyalgia: A randomized, double‐blind, placebo‐controlled, multicenter trial
Open accessAbstract
Objective: To assess the efficacy and safety of gabapentin in patients with fibromyalgia. Methods: A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treating pain associated with fibromyalgia. The primary outcome measure was the Brief Pain Inventory (BPI) average pain severity score (range 0–10, where 0 = no pain and 10 = pain as bad as you can imagine). Response to treatment was defined as a reduction of ≥30% in this score. The primary analysis of efficacy for continuous variables was a longitudinal analysis of the intent‐to‐treat sample, with treatment‐by‐time interaction as the measure of effect. Results: Gabapentin‐treated patients displayed a significantly greater improvement in the BPI average pain severity score (P= 0.015; estimated difference between groups at week 12 = −0.92 [95% confidence interval −1.75, −0.71]). A significantly greater proportion of gabapentin‐treated patients compared with placebo‐treated patients achieved response at end point (51% versus 31%;P= 0.014). Gabapentin compared with placebo also significantly improved the BPI average pain interference score, the Fibromyalgia Impact Questionnaire total score, the Clinical Global Impression of Severity, the Patient Global Impression of Improvement, the Medical Outcomes Study (MOS) Sleep Problems Index, and the MOS Short Form 36 vitality score, but not the mean tender point pain threshold or the Montgomery Asberg Depression Rating Scale. Gabapentin was generally well tolerated. Conclusion: Gabapentin (1,200–2,400 mg/day) is safe and efficacious for the treatment of pain and other symptoms associated with fibromyalgia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Diagnostic and Statistical Manual of Mental Disorders
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5485 · Cited by 10,169
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Self-citationFarrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
(1991) · PubMed · Cited by 1,837
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,064
A summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L. K., Martin, S. A., Sharma, U., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20983 · Cited by 654
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
Rice, A. S. C., & Maton, S. (2001) · Pain · doi:10.1016/s0304-3959(01)00407-9 · Cited by 596
Possible Deficiencies of Pain Modulation in Fibromyalgia
Lautenbacher, S., & Rollman, G. B. (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199709000-00003 · Cited by 545
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471
Self-citationMeasuring Functioning and Well-Being
Stewart, A., & Ware, J. E. (1992) · Cited by 458
Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and Review
Arnold, L. M., Keck, P. E., & Welge, J. A. (2000) · Psychosomatics · doi:10.1176/appi.psy.41.2.104 · Cited by 448
Self-citationMorello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F., & Sahagian, G. A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1931 · Cited by 445
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
Backonja, M., & Glanzman, R. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90011-7 · Cited by 425
Treatment of Social Phobia With Gabapentin: A Placebo-Controlled Study
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 395
Rank-Based Estimation and Associated Inferences for Linear Models With Cluster Correlated Errors
Kloke, J. D., McKean, J. W., & Rashid, M. M. (2009) · Journal of the American Statistical Association · doi:10.1198/jasa.2009.0116 · Cited by 357
Efficacy of Gabapentin in Migraine Prophylaxis
Mathew, N. T., Rapoport, A., Saper, J., Magnus, L., Klapper, J., Ramadan, N., Stacey, B., & Tepper, S. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.111006119.x · Cited by 343
SENSITIZATION OF PAIN PATHWAYS IN THE SPINAL CORD: CELLULAR MECHANISMS
BARANAUSKAS, G., & NISTRI†, A. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00067-1 · Cited by 295
Pressure threshold meter: its use for quantification of tender spots.
Fischer, A. A. (1986) · PubMed · Cited by 285
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 279
Arnold, L. M., Hess, E. V., Hudson, J. I., Welge, J. A., Berno, S. E., & Keck, P. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01089-0 · Cited by 261
Self-citationBennett, R. M. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.4.385 · Cited by 255
Abdi, S., Lee, D. H., & Chung, J. M. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199812000-00027 · Cited by 250
The neuroscience and endocrinology of fibromyalgia
Pillemer, S. R., Bradley, L. A., Crofford, L. J., Moldofsky, H., & Chrousos, G. P. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401103 · Cited by 229
7 Intention to Treat in Clinical Trials
Fisher, L., Dixon, D., Herson, J., Frankowski, R., Hearron, M., & Peace, K. (2017) · Statistical Issues in Drug Research and Development · doi:10.1201/9780203738610-8 · Cited by 227
Gabapentin Suppresses Ectopic Nerve Discharges and Reverses Allodynia in Neuropathic Rats
Pan, H.-L., Eisenach, J. C., & Chen, S.-R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38054-1 · Cited by 206
Interpreting Incomplete Data in Studies of Diet and Weight Loss
Ware, J. H. (2003) · New England Journal of Medicine · doi:10.1056/nejme030054 · Cited by 205
Gabapentin Increases Slow‐wave Sleep in Normal Adults
Foldvary‐Schaefer, N., De Leon Sanchez, I., Karafa, M., Mascha, E., Dinner, D., & Morris, H. H. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.21002.x · Cited by 187
Woolf, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00009 · Cited by 185
Evidence of involvement of central neural mechanisms in generating fibromyalgia pain
Staud, R. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0038-5 · Cited by 183
THE RELATIONSHIP BETWEEN FIBROMYALGIA AND MAJOR DEPRESSIVE DISORDER
Hudson, J. I., & Pope, H. G. (1996) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70273-8 · Cited by 122
Self-citationUrban, M. O., Ren, K., Park, K. T., Campbell, B., Anker, N., Stearns, B. A., Aiyar, J., Belley, M. L., Cohen, C. J., & Bristow, L. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081778 · Cited by 72
Statistical issues in drug research and development
(1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90475-l · Cited by 64
The relationship of fibromyalgia to neuropathic pain syndromes.
Crofford, L. J. (2005) · PubMed · Cited by 32
Is fibromyalgia a neuropathic pain syndrome?
Rowbotham, M. C. (2005) · PubMed · Cited by 30
Cited by
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Arendt-Nielsen, L., & Yarnitsky, D. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.02.002 · Cited by 547
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 307
Bair, M. J., & Krebs, E. E. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202003030 · Cited by 298
Fibromyalgia Pathogenesis and Treatment Options Update
Chinn, S., Caldwell, W., & Gritsenko, K. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0556-x · Cited by 296
Metadata
- Authors
- Arnold, L. M., Goldenberg, D. L., Stanford, S. B., Lalonde, J. K., Sandhu, H. S., Keck, P. E., Welge, J. A., Bishop, F., Stanford, K. E., Hess, E. V., & Hudson, J. I.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-03-28
- Volume
- 56
- Issue
- 4
- Pages
- 1336-1344
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2009137120
- Cited by
- 329
- References
- 44
- FWCI
- 23.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.